Celltrio

Santa Clara, United States Founded: 2018 • Age: 8 yrs
Developer of automated biobanking and cell culture systems

About Celltrio

Celltrio is a Healthcare company based in Santa Clara (United States) founded in 2018. Celltrio has raised $15 million across 1 funding round from investors including Premier Partners. Celltrio offers products and services including RoboCell, RoboStor, and Bioflow. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Lab Automation. Its competitors include Multiply Labs, ThermoGenesis and Aopia Biosciences; 1 of its 3 listed competitors has raised funding.

Company details

Developer of automated biobanking and cell culture systems. It has developed CryoStor and RoboStor lines of liquid nitrogen freezers for biobanking applications. The company has also developed integrated robotic solutions which combine incubators, centrifuges and liquid handlers using software and LIMS systems.

  • Headquarters Santa Clara, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website celltrio.com
Key Metrics
  • Total Equity Funding
    $15M (USD)

    in 1 rounds

  • Latest Funding Round
    $15M (USD), Series B

    Jun 2025

  • Investors

Products & Services of Celltrio

Celltrio offers a comprehensive portfolio of products and services, including RoboCell, RoboStor, and Bioflow.

RoboCell
Cell Line Automation Platform

Automates cell maintenance, culture, and assays for biological research.

RoboStor
Cryogenic Sample Management

Handles LN2 storage and retrieval for biobanking applications.

Bioflow
Workflow Management Platform

Manages cell culture processes and data monitoring in real-time.

Funding Insights of Celltrio

Celltrio has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $15M
  • Total Rounds 1
  • Last Round Series B β€” $15M
  • First Round $15M

    (Jun 2025)

  • Investors Count 1

All 1 funding rounds of Celltrio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2025$15MSeries B–Premier Partners
–
Valuation history

1 investors in total: 1 institutional.

Investors in Celltrio

Celltrio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Premier Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity & venture capital firm
premierpartners.co.krSeoul, South Korea
Premium access

Investor details for Celltrio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Celltrio

10 people are tracked at Celltrio (5 in leadership, 5 in team).

NameRoleGroup
Charlie Duncheon
CEOLeadership
Raphael Kim
Vice President Of Software EngineeringLeadership
Jeff Baird
Chief Operating OfficerLeadership
Jaewook Ha
Vice President Of Product Management, CelltrioLeadership
Mark Freitas
Head Of OperationsLeadership
Andrew Mesfin
Senior Manufacturing EngineerTeam
Jun Hur
Software EngineerTeam
Nicholas Wong
Senior System EngineerTeam
Annie Lo
Systems EngineerTeam
James Davis
Systems Scientist And Business DevelopmentTeam
Premium access

Complete people profiles for Celltrio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Celltrio

2 dated milestones of Celltrio across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Celltrio is founded.
  2. Funding First funding round of $15.0M.

Competitors of Celltrio

Celltrio has 3 listed competitors in our database, 1 of them funded. They include Multiply Labs, ThermoGenesis and Aopia Biosciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
multiplylabs.com2016San Francisco, United States$41.32M34
Precision medicines are manufactured via robotic systems for cell therapies.
thermogenesis.com1986Rancho Cordova, United States41
Automated technologies for cell-based therapeutics and bio-processing are developed.
aopiabio.com2019Pleasanton, United States
Develops innovative tools for EV isolation and bioengineering in biotechnology field.
Premium access

Detailed competitors of Celltrio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Celltrio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Celltrio

Premium access

Complete news archive for Celltrio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Celltrio

Celltrio was founded in 2018 and raised its 1st funding round 7 years after it was founded.

Celltrio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.

Celltrio is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series B of $15M, raised on Jun 2025.

Developer of automated biobanking and cell culture systems. It has developed CryoStor and RoboStor lines of liquid nitrogen freezers for biobanking applications. The company has also developed integrated robotic solutions which combine incubators, centrifuges and liquid handlers using software and LIMS systems.

Celltrio's top competitors include Multiply Labs, ThermoGenesis and Aopia Biosciences.

Celltrio offers RoboCell, RoboStor, and Bioflow.

Celltrio has 1 investor. Key investors include Premier Partners.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available